Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya: protocol for a prospective cohort study (Tabiri Study)

dc.contributor.authorOyungu, Eren
dc.contributor.authorEl Kebbi, Ola
dc.contributor.authorVreeman, Rachel Christine
dc.contributor.authorNyandiko, Winstone Mokaya
dc.contributor.authorMonahan, Patrick O.
dc.contributor.authorTu, Wanzhu
dc.contributor.authorKhaitan, Alka K.
dc.contributor.authorDesta, Zeruesenay
dc.contributor.authorSlogrove, Amy L.
dc.contributor.authorHumphrey, John M.
dc.contributor.authorWere, Edwin O.
dc.contributor.authorPatel, Rena C.
dc.contributor.authorCarlucci, James G.
dc.contributor.authorWools-Kaloustian, Kara K.
dc.contributor.authorMchenry, Megan S.
dc.contributor.departmentEmergency Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:41:57Z
dc.date.available2025-01-24T11:41:57Z
dc.date.issued2022
dc.description.abstractIntroduction For the growing number of children with in utero and postpartum exposure to HIV and/or antiretrovirals, it is unclear which exposures or risk factors play a significant role in predicting worse neurodevelopmental outcomes. This protocol describes a prospective longitudinal cohort study of infants born to mothers living with HIV and those born to mothers without HIV. We will determine which risk factors are most predictive of child neurodevelopment at 24 months. We aim to create a risk assessment tool to help predict which children are at risk for worse neurodevelopment outcomes. Methods and analysis This study leverages an existing Kenyan cohort to prospectively enrol 500 children born to mothers living with HIV and 500 to those without HIV (n=1000 total) and follow them from birth to age 24 months. The following factors will be measured every 6 months: infectious morbidity and biological/sociodemographic/psychosocial risk factors. We will compare these factors between the two groups. We will then measure and compare neurodevelopment within children in both groups at 24 months of age using the Child Behaviour Checklist and the Bayley Scales of Infant and Toddler Development, third edition. Finally, we will use generalised linear mixed modelling to quantify associations with neurodevelopment and create a risk assessment tool for children ≤24 months. Ethics and dissemination The study is approved by the Moi University's Institutional Research and Ethics Committee (IREC/2021/55; Approval #0003892), Kenya's National Commission for Science, Technology and Innovation (NACOSTI, Reference #700244) and Indiana University's Institutional Review Board (IRB Protocol #110990). This study carries minimal risk to the children and their mothers, and all mothers will provide written consent for participation in the study. Results will be disseminated to maternal child health clinics within Uasin Gishu County, Kenya and via papers submitted to peer-reviewed journals and presentation at international conferences. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2022-061051
dc.identifier.eid2-s2.0-85127479111
dc.identifier.pmid35379648
dc.identifier.urihttp://hdl.handle.net/10938/29916
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.ispartofBMJ Open
dc.sourceScopus
dc.subjectDelirium & cognitive disorders
dc.subjectHiv & aids
dc.subjectInfectious disease/hiv
dc.subjectPaediatrics
dc.subjectChild development
dc.subjectChild, preschool
dc.subjectFemale
dc.subjectHiv infections
dc.subjectHumans
dc.subjectInfant
dc.subjectKenya
dc.subjectLongitudinal studies
dc.subjectMothers
dc.subjectPregnancy
dc.subjectPregnancy complications, infectious
dc.subjectProspective studies
dc.subjectAdult
dc.subjectArticle
dc.subjectBayley scales of infant development
dc.subjectBrain development
dc.subjectChild
dc.subjectChild behavior checklist
dc.subjectClinical protocol
dc.subjectCohort analysis
dc.subjectComparative study
dc.subjectControlled study
dc.subjectHuman
dc.subjectHuman immunodeficiency virus infected patient
dc.subjectMajor clinical study
dc.subjectMother
dc.subjectPredictive value
dc.subjectProspective study
dc.subjectRisk assessment
dc.subjectRisk factor
dc.subjectSocial psychology
dc.subjectSociodemographics
dc.subjectComplication
dc.subjectHuman immunodeficiency virus infection
dc.subjectLongitudinal study
dc.subjectPregnancy complication
dc.subjectPreschool child
dc.titlePredicting neurodevelopmental risk in children born to mothers living with HIV in Kenya: protocol for a prospective cohort study (Tabiri Study)
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1821.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format